Deep, focused subsequent-technology sequencing has unveiled that subclonal mutations (i.e., All those present in only a portion of tumor cells) may be detected for all driver genes and are associated with swift condition progression and lousy outcome.eleven–thirteen This is especially relevant for TP53 mutations offered The truth that, as describ